The COVID Hunter is a non-invasive, touchless, immediate, and portable detector of the virus SARS-CoV-2 which causes the disease COVID-19, demonstrating >99% specificity and sensitivity within 0-2 meters (6.5 feet) on surfaces, through glass or transparent material, and inside the human body.
Nobel Prize-winning molecular geneticist, Professor Mario Capecchi, serves as an advisor to AMSI on this and the company’s other breakthrough technologies - including a cure for allergic airway disease and chronic obstructive pulmonary disease (COPD) that is currently in the preliminary phase of FDA approval. AMSI technology builds upon research performed by Professor Maria Grant at the University of Florida and the University of Alabama at Birmingham and the work of Dr. Adeeb Al-Zoubi at Stem Cells Arabia in Jordan, the sister company of AMSI.
AMSI is working with Biologics Consulting Group, Inc. to handle the FDA Emergency Use Authorization (EUA) submission for The COVID Hunter.
“The handheld COVID Hunter will revolutionize the way SARS-CoV-2 (including mutated strains) is detected, slowing the spread of the deadly virus, saving lives, and returning life to ‘normal’ in the near future,” explains Donald Redman, Co-founder and Chief Executive Officer of AMSI.
The distribution of The COVID Hunter would allow rooms, restaurants, venues, vehicles, hospitals, hotels, schools, offices, and others to be scanned for SARS-CoV-2. Surfaces with the virus will be cleaned and retested to ensure the disinfectant was successful. Once areas are clean, persons and objects entering the area would be scanned to screen for the virus.
COVID-free “bubbles” would make social distancing, masks, and occupancy restrictions obsolete, allowing for the rapid resumption of common activities.
“We utilized specific spectra of electromagnetic waves to identify the unique ‘thumbprint’ of the virus,” explains Dr. Adeeb Al-Zoubi, Co-Founder and Chief Scientific Officer of AMSI, “As new mutations are found, The COVID Hunter is capable of being ‘updated’ to detect new strains of the virus, making it a critical weapon to defeat the spread of the pandemic.”
The proprietary non-invasive remote technology utilizes a combination of radiofrequency (RF) and infrared (IR) electromagnetic waves. Signals emitted from a tested medium are analyzed to detect a characteristic relaxation time for the chemically-stable molecule. The device and methodology work non-invasively for remotely detecting a marker of COVID-19 disease in a subject sample.
The device comprises of a transmitter that is configured to transmit IR to RF energy into a sample, a receiving circuitry that is configured to detect RF energy emitted from the sample in response to stimulation of the sample IR and RF energy, a signal processing circuitry that is configured to analyze the RF energy detected by the receiving circuitry to determine a resonant frequency, and a computer processor that is configured to identify the presence of a virus in the sample based on the determined resonant frequency.
Frontline healthcare workers worldwide are the leaders of the fight against the pandemic and must have access to the supply of this product at the outset. The COVID Hunter technology will also go to the heads of governments worldwide for immediate positioning in their respective battles against the pandemic.
To meet the demand of the international market, The COVID Hunter will be manufactured in multiple regions including Central America, Southeast Asia, and the Middle East.
Advanced Medical Solutions International is a research and development firm based in West Palm Beach, Florida with almost 7 years in business. Through strong international partnerships, AMSI produces cutting-edge medical solutions to humanity’s greatest public health challenges including SARS-CoV-2, COPD, IVF, and diabetes.
"COVID-free 'bubbles' would make social distancing, masks, and occupancy restrictions obsolete, allowing for the rapid resumption of common activities."